Evidence map›Paper›PMID 32107606›Full record

ArticleArchives of gynecology and obstetrics2020

H19 regulates angiogenic capacity of extravillous trophoblasts by H19/miR-106a-5p/VEGFA axis.

Hong Zeng, Dongmei He, Hebin Xie, Yuhao Zhao, Zhaoqun Peng, Huan Deng, Jinyue Hu, Binyuan Jiang, Nenghui Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Functional Roles of lncRNAs in Recurrent Pregnancy Loss: A Review Study.International journal of fertility & sterility · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hong ZengReproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, 410008, China.
Dongmei HeReproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, 410008, China.
Hebin XieChangsha Central Hospital, Changsha, 410004, China.
Yuhao ZhaoReproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, 410008, China.
Zhaoqun PengReproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, 410008, China.
Huan DengReproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, 410008, China.
Jinyue HuChangsha Central Hospital, Changsha, 410004, China.
Binyuan JiangChangsha Central Hospital, Changsha, 410004, China.
Nenghui LiuReproductive Medicine Center, Xiangya Hospital of Central South University, Changsha, 410008, China. dr_liunenghui@126.com.ORCID http://orcid.org/0000-0002-7063-707X
Central South University · CNChangsha Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the role and underlying mechanism of H19 in regulating angiogenic capacity of extravillous trophoblasts.

methodsGain and loss of function experiments were performed using a human first-trimester extravillous trophoblast (EVT) cell line, HTR-8/SVneo cells. H19 was overexpressed or knocked down in HTR-8 cells by transfecting plasmid harboring whole-length H19 sequence (pH19) or siRNA specially targeting H19, respectively (siH19). Cell migration and tube-formation assay were assessed in the indicated groups. Gene expression was detected by RT-qPCR, Western blot, and ELISA assay.

resultsOverexpression of H19 in EVT cells increased cell migration and tube formation, while downregulation of H19 in EVT cells decreased cell migration and tube formation. Furthermore, we found that H19 played its role by VEGFA. In addition, we demonstrated the H19/miR-106a-5p/VEGFA regulatory axis in EVT. Experiments of the clinical specimen showed that H19 was very abundantly expressed in human first-trimester trophoblasts, and we found that the expression of H19 and VEGFA were significantly downregulated in the villous tissues from idiopathic recurrent miscarriage (RM) patients; moreover, the expression of H19 and VEGFA was positively correlated.

conclusionH19/miR-106a-5p/VEGFA axis plays a role in regulating the angiogenic capacity of EVT, which might contribute to idiopathic RM.

Indexed as

AdultFemaleHumansMicroRNAsPregnancyPregnancy Trimester, FirstRNA, Long NoncodingTrophoblastsYoung AdultH19 long non-coding RNAMicroRNAsRNA, Long NoncodingAngiogenesisLong non-coding RNAmiR-106a-5pRecurrent miscarriage

Identifiers

PMID32107606
OpenAlexW3006769323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.